Managing Hyperglycemia in Hospitalized Patients

Clinical Cornerstone

Volumn 8, Issue 2, 2007, Pages 44-57

  Braithwaite, Susan S ^a   Mehrotra, Hetal P ^a   Robertson, Beverly ^b   McElveen, Linda M ^b   Thompson, Cara L ^b  

^a Point of Care Testing Administrator University of North Carolina Hospitals Chapel ^*

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; DRUG DERIVATIVE; INSULIN;

ARTICLE; BEDTIME DOSAGE; CARBOHYDRATE INTAKE; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; DOSE CALCULATION; GLYCEMIC CONTROL; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSION RATE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN SENSITIVITY; INSULIN TREATMENT; INTENSIVE CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOMYELITIS; PATIENT AUTONOMY; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRESCRIPTION; SELF CARE; ALGORITHM; HOSPITALIZATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

ALGORITHMS; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; INJECTIONS, SUBCUTANEOUS; INSULIN; SELF CARE;

EID: 41949105099     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(09)60007-7     Document Type: Article

References (59)

1. Clement S., Braithwaite S.S., Magee M.F., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27 (2004) 553-591
2. Garber A.J., Moghissi E.S., Bransome Jr. E.D., et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10 (2004) 77-82
3. Braithwaite S.S., Godara H., Song H.-J., and Rock P. No patient left behind: Evaluation and design of intravenous insulin infusion algorithms. Endocr Pract 12 Suppl 3 (2006) 72-78
4. Wilson M., Weinreb J., and Hoo G.W. Intensive insulin therapy in critical care: A review of 12 protocols. Diabetes Care 30 (2007) 1005-1011
5. Ku S.Y., Sayre C.A., Hirsch I.B., and Kelly J.L. New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. Jt Comm J Qual Patient Saf 31 (2005) 141-147
6. Davis E.D., Harwood K., Midgett L., et al. Implementation of a new intravenous insulin method on intermediate-care units in hospitalized patients. Diabetes Educ 31 (2005) 818-823
7. Boullu-Sanchis S., Ortega F., Chabrier G., et al. Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients. Diabetes Metab 32 (2006) 350-357
8. Plank J., Blaha J., Cordingley J., et al. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 29 (2006) 271-276
9. Furnary A.P., Zerr K.J., Grunkemeier G.L., and Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67 (1999) 352-362
10. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
11. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
12. Van den Berghe G. Insulin therapy for the critically ill patient. Clin Cornerstone 5 (2003) 56-63
13. Markovitz L.J., Wiechmann R.J., Harris N., et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract 8 (2002) 10-18
14. Bode B.W., Braithwaite S.S., Steed R.D., and Davidson P.C. Intravenous insulin infusion therapy: Indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 10 Suppl 2 (2004) 71-80
15. Goldberg P.A., Siegel M.D., Sherwin R.S., et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 27 (2004) 461-467
16. Goldberg P.A., Roussel M.G., and Inzucchi S.E. Clinical results of an updated insulin infusion protocol in critically ill patients. Diabetes Spectrum 18 (2005) 188-191
17. Davidson P.C., Steed R.D., and Bode B.W. Glucommander: A computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care 28 (2005) 2418-2423
18. Osburne R.C., Cook C.B., Stockton L., et al. Improving hyperglycemia management in the intensive care unit: Preliminary report of a nurse-driven quality improvement project using a redesigned insulin infusion algorithm. Diabetes Educ 32 (2006) 394-403
19. Braithwaite S.S., Edkins R., Macgregor K.L., et al. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions. Diabetes Technol Ther 8 (2006) 476-488
20. Boulkina L.S., and Braithwaite S.S. Practical aspects of intensive insulinization in the intensive care unit. Curr Opin Clin Nutr Metab Care 10 (2007) 197-205
21. cross step next estimate". Diabetes Technology Society Meeting Abstracts (2006), Diabetes Technology Society A50 Abstract.
22. Leahy J.L. Insulin management of diabetic patients on general medical and surgical floors. Endocr Pract 12 Suppl 3 (2006) 86-90
23. Braithwaite S.S. The transition from insulin infusions to long-term diabetes therapy: The argument for insulin analogs. Semin Thorac Cardiovasc Surg 18 (2006) 366-378
24. Ashwell S.G., Amiel S.A., Bilous R.W., et al. Improved glycaemic control with insulin glargine plus insulin lispro: A multicentre, randomized, cross-over trial in people with type 1 diabetes. Diabet Med 23 (2006) 285-292
25. Hermansen K., Fontaine P., Kukolja K.K., et al. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia 47 (2004) 622-629
26. Hirsch I.B. Insulin analogues. N Engl J Med 352 (2005) 174-183
27. Braithwaite S.S. Case study: Five steps to freedom: Dose titration for type 2 diabetes using basal-prandial-correction insulin therapy. Clin Diabetes 23 (2005) 39-43
28. Edelman S., Dailey G., Flood T., et al. A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes. Osteopath Med Prim Care 1 (2007) 9. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubm edid=1744824 Accessed August 6, 2007.
29. Queale W.S., Seidler A.J., and Brancati F.L. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 157 (1997) 545-552
30. Umpierrez G.E., Smiley D., Zisman A., et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 30 (2007) 2181-2186
31. Baldwin D., Villanueva G., McNutt R., and Bhatnagar S. Eliminating inpatient sliding scale insulin: A reeducation project with medical house staff. Diabetes Care 28 (2005) 1008-1011
32. Schoeffler J.M., Rice D.A., and Gresham D.G. 70/30 Insulin algorithm versus sliding scale insulin. Ann Pharmacother 39 (2005) 1606-1609
33. Golightly L.K., Jones M.A., Hamamura D.H., et al. Management of diabetes mellitus in hospitalized patients: Efficiency and effectiveness of sliding scale insulin therapy. Pharmacotherapy 26 (2006) 1421-1432
34. Hirsch I.B., and Braithwaite S.S. Sliding scale insulin therapy: An ineffective option for inpatient glycemic control. Resident & Staff Physician (2007) 53. Available at: http://www.residentandstaff.com/issues/articles/2007-02_08.asp Accessed August 6, 2007.
35. Translation of the diabetes nutrition recommendations for health care institutions. Diabetes Care 26 Suppl 1 (2003) S70-S72
36. Mucha G.T., Merkel S., Thomas W., and Bantle J.P. Fasting and insulin glargine in individuals with type 1 diabetes. Diabetes Care 27 (2004) 1209-1210
37. Braithwaite S.S., Buie M.M., Thompson C.L., et al. Hospital hypoglycemia: Not only treatment but also prevention. Endocr Pract 10 Suppl 2 (2004) 71-80
38. Magee M.F., and Clement S. Subcutaneous insulin therapy in the hospital setting: Issues, concerns, and implementation. Endocr Pract 10 Suppl 2 (2004) 81-88
39. Thompson C.L., Dunn K.C., Menon M.C., et al. Hyperglycemia in the hospital. Diabetes Spectr 18 (2005) 20-27
40. Campbell K.B., and Braithwaite S.S. Hospital management of hyperglycemia. Clin Diabetes 22 (2004) 81-88
41. Trence D.L., Kelly J.L., and Hirsch I.B. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: Time for change. J Clin Endocrinol Metab 88 (2003) 2430-2437
42. Mulhauser I., Jorgens V., Berger M., et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: Improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25 (1983) 470-476
43. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: Dose Adjustment For Normal Eating (DAFNE) randomised controlled trial. BMJ 325 (2002) 746-752
44. Samann A., Muhlhauser I., Bender R., et al. Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis. Diabetes Care 29 (2006) 2196-2199
45. Hoogma R.P., Hammond P.J., Gomis R., et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: Results of the 5 Nations Trial. Diabet Med 23 (2006) 141-147
46. Berthe E., Lireux B., Coffin C., et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: A comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res 39 (2007) 224-229
47. Pickup J., Mattock M., and Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials. BMJ 324 (2002) 705-710
48. DeVries J.H., Snoek F.J., Kostense P.J., et al. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 25 (2002) 2074-2080
49. Rudolph J.W., and Hirsch I.B. Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic. Endocr Pract 8 (2002) 401-405
50. Raskin P., Bode B.W., Marks J.B., et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study. Diabetes Care 26 (2003) 2598-2603
51. Lepore G., Dodesini A.R., Nosari I., and Trevisan R. Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: An open parallel long-term study. Diabetes Nutr Metab 17 (2004) 84-89
52. Retnakaran R., Hochman J., DeVries J.H., et al. Continuous subcutaneous insulin infusion versus multiple daily injections: The impact of baseline A1c. Diabetes Care 27 (2004) 2590-2596
53. Fahlen M., Eliasson B., and Oden A. Optimization of basal insulin delivery in type 1 diabetes: A retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine. Diabet Med 22 (2005) 382-386
54. Hirsch I.B., Bode B.W., Garg S., et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 28 (2005) 533-538
55. Herman W.H., Ilag L.L., Johnson S.L., et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 28 (2005) 1568-1573
56. Roze S., Valentine W.J., Zakrzewska K.E., and Palmer A.J. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of type 1 diabetes in the UK. Diabet Med 22 (2005) 1239-1245
57. Lee S.W., Im R., and Magbual R. Current perspectives on the use of continuous subcutaneous insulin infusion in the acute care setting and overview of therapy. Crit Care Nurs 27 (2004) 172-184
58. White Jr. W.A., Montalvo H., and Monday J.M. Continuous subcutaneous insulin infusion during general anesthesia: A case report. AANA J 72 (2004) 353-357
59. Cook C.B., Boyle M.E., Cisar N.S., et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: Proposed guidelines and outcome measures. Diabetes Educ 31 (2005) 849-857